{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:57:44Z","timestamp":1791446264361,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K06911"],"award-info":[{"award-number":["23K06911"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jns.2025.123414","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T21:36:25Z","timestamp":1738272985000},"page":"123414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Cardiac involvement and anti-striational antibodies in immune-mediated necrotizing myopathy"],"prefix":"10.1016","volume":"470","author":[{"given":"Kaori","family":"Sumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruaki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konen","family":"Obayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Aso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinta","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2025.123414_bb0005","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamaneurol.2015.1207","article-title":"Clinical features and treatment outcomes of necrotizing autoimmune myopathy","volume":"72","author":"Kassardjian","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2025.123414_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jns.2025.123414_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2025.123414_bb0020","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.mayocp.2020.03.032","article-title":"Cardiac and respiratory complications of necrotizing autoimmune myopathy","volume":"95","author":"Triplett","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jns.2025.123414_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.670784","article-title":"The clinicopathological distinction between seropositive and seronegative immune-mediated necrotizing myopathy in China","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2025.123414_bb0030","article-title":"Corrigendum: characteristics of cardiac involvement in immune-mediated necrotizing myopathy","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jns.2025.123414_bb0035","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1038\/s41598-019-41730-z","article-title":"Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and\/or myocarditis","volume":"9","author":"Kufukihara","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2025.123414_bb0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2005.08.017","article-title":"Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis","volume":"170","author":"Suzuki","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2025.123414_bb0045","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.2169\/internalmedicine.8772-21","article-title":"Saotome, nivolumab-induced myositis and myocarditis with positive anti-titin antibody and anti-voltage-gated potassium channel Kv1.4 antibody","volume":"61","author":"Ono","year":"2022","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2025.123414_bb0050","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/archneurol.2009.229","article-title":"Autoimmune targets of heart and skeletal muscles in myasthenia gravis","volume":"66","author":"Suzuki","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2025.123414_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, the Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2025.123414_bb0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/cen3.12302","article-title":"Enzyme-linked immunosorbent assays for diagnosis of immune-mediated necrotizing myopathy","volume":"7","author":"Ikemoto","year":"2016","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.jns.2025.123414_bb0065","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2025.123414_bb0070","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","article-title":"Antibody to signal recognition particle in polymyositis","volume":"33","author":"Targoff","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2025.123414_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/PL00007850","article-title":"Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies","volume":"249","author":"Hengstman","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2025.123414_bb0080","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2025.123414_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2025.123414_bb0090","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2025.123414_bb0095","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","article-title":"Rituximab therapy for myopathy associated with anti\u2013signal recognition particle antibodies: a case series","volume":"62","author":"Valiyil","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jns.2025.123414_bb0100","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","article-title":"Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome: disease progression and neurological outcome","volume":"69","author":"Suzuki","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2025.123414_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients","volume":"10","author":"Suzuki","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2025.123414_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10067-014-2512-7","article-title":"Inflammatory myopathy with anti-SRP antibodies: case series of a south Australian cohort","volume":"34","author":"Basnayake","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jns.2025.123414_bb0115","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2025.123414_bb0120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12026-015-8774-6","article-title":"Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study","volume":"64","author":"Picard","year":"2016","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jns.2025.123414_bb0125","first-page":"766","article-title":"Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody","volume":"35","author":"De Souza","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jns.2025.123414_bb0130","first-page":"291","article-title":"Immune-mediated necrotizing myopathy in a multi-ethnic Malaysian cohort","volume":"26","author":"Tan","year":"2021","journal-title":"Neurol. Asia"},{"key":"10.1016\/j.jns.2025.123414_bb0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.55563\/clinexprheumatol\/5y19bb","article-title":"Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibodies: incidence using different testing criteria, and case series","volume":"40","author":"Joseph","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jns.2025.123414_bb0140","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3988\/jcn.2024.0007","article-title":"Clinical manifestations and prognosis of anti-signal-recognition-particle myositis","volume":"20","author":"Baek","year":"2024","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.jns.2025.123414_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-248535","article-title":"Seronegative immune-mediated necrotising myopathy complicated by fulminant myocarditis resulting in cardiogenic shock and cardiac arrest","volume":"15","author":"Tsang","year":"2022","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jns.2025.123414_bb0150","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.cardfail.2020.09.131","article-title":"Necrotizing myopathy resulting in myocarditis and sudden death","volume":"26","author":"Sanchez","year":"2020","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.jns.2025.123414_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12883-020-1599-5","article-title":"Secondary cardiac involvement in anti-SRP-antibody-positive myopathy: an 87-year-old woman with heart failure symptoms as the first clinical presentation","volume":"20","author":"Hara","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2025.123414_bb0160","article-title":"Necrotizing myopathy presenting as congestive heart failure and life-threatening ventricular arrhythmias: a case report","volume":"5","author":"Lim","year":"2021","journal-title":"Eur. Heart J. Case Rep."},{"key":"10.1016\/j.jns.2025.123414_bb0165","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.2169\/internalmedicine.6355-20","article-title":"An autopsy case of antibody-negative immune-mediated necrotizing myopathy with severe cardiac involvement","volume":"60","author":"Tamura","year":"2021","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2025.123414_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.571716","article-title":"Case report: immune mediated necrotizing myopathy with IgG antibodies to 3-hydroxy-3-methylglutaryl-coenzyme a reductase (HMGCR) may present with acute systolic heart failure","volume":"11","author":"Ghannam","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2025.123414_bb0175","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.21037\/tlcr-20-1095","article-title":"Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy-case report","volume":"10","author":"Schiopu","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.jns.2025.123414_bb0180","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/03009742.2020.1760346","article-title":"A case of myositis with dropped head syndrome and anti-titin antibody positivity induced by pembrolizumab","volume":"49","author":"Takahashi","year":"2020","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jns.2025.123414_bb0185","article-title":"Anti-Kv1.4 antibody without myasthenia gravis: a rare cause of autoimmune myocarditis and myositis","volume":"9","author":"Kuyama","year":"2023","journal-title":"JACC Case Rep."},{"key":"10.1016\/j.jns.2025.123414_bb0190","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.2169\/internalmedicine.6834-20","article-title":"Marked respiratory failure in an ambulant patient with immune-mediated necrotizing myopathy and anti-Kv1.4 and anti-titin antibodies","volume":"60","author":"Sugiyama","year":"2021","journal-title":"Intern. Med."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T21:57:05Z","timestamp":1740693425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25000310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":38,"alternative-id":["S0022510X25000310"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123414","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac involvement and anti-striational antibodies in immune-mediated necrotizing myopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123414"}}